AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $7,306,000 | -88.5% | 302,290 | -70.7% | 0.26% | -87.6% |
| Q3 2018 | $63,527,000 | -28.4% | 1,032,127 | -21.5% | 2.11% | -25.3% |
| Q2 2018 | $88,780,000 | +36.4% | 1,314,290 | +9.5% | 2.82% | +27.3% |
| Q1 2018 | $65,100,000 | +493.5% | 1,200,000 | +242.9% | 2.21% | +323.3% |
| Q1 2015 | $10,969,000 | +606.8% | 350,000 | +366.7% | 0.52% | +553.8% |
| Q3 2014 | $1,552,000 | – | 75,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 805,217 | $14,212,000 | 4.99% |
| DAFNA Capital Management LLC | 156,842 | $2,768,000 | 2.34% |
| NORTHPOINTE CAPITAL LLC | 1,034,400 | $18,257,000 | 2.15% |
| HARVEY CAPITAL MANAGEMENT INC | 223,200 | $3,856,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,211,644 | $39,036,000 | 1.30% |
| Boulegeris Investments, Inc. | 88,660 | $1,565,000 | 1.12% |
| Partner Investment Management, L.P. | 43,623 | $770,000 | 1.08% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 150,000 | $2,648,000 | 0.92% |
| PFM Health Sciences, LP | 1,851,564 | $32,680,000 | 0.83% |
| Benchmark Capital Advisors | 55,400 | $978,000 | 0.69% |